Company Filing History:
Years Active: 2025
Title: De Zoysa Pathmendrra Mahanama: Innovator in Ocular Drug Delivery
Introduction
De Zoysa Pathmendrra Mahanama is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of ocular drug delivery through his innovative research and development. His work focuses on enhancing the effectiveness of eye drops using advanced nanoparticle technology.
Latest Patents
Mahanama holds a patent for "Eye drops containing chitosan nanoparticles in which PDRN is encapsulated, and preparation method therefor." This invention relates to nucleic acid fragment-encapsulated polymer nanoparticles and a method of preparing them. The polymer used is a mucoadhesive polymer, specifically chitosan, while the nucleic acid fragment is polydeoxyribonucleotide (PDRN). These nanoparticles can be utilized as eye drops, adhering to the ocular mucous membrane and allowing for a slow release of nucleic acid fragments. This innovative approach increases patient convenience and reduces costs by maintaining high efficiency even with a small drug dosage.
Career Highlights
Mahanama is currently associated with Zerone Bio Inc., where he continues to advance his research in drug delivery systems. His work has garnered attention for its potential to improve treatment outcomes for patients requiring ocular medications.
Collaborations
Mahanama collaborates with talented individuals such as Dong Rack Choi and Thi Thu Thao Nguyen, contributing to a dynamic research environment that fosters innovation.
Conclusion
De Zoysa Pathmendrra Mahanama's contributions to ocular drug delivery through his patented technology exemplify the impact of innovative research in medicine. His work not only enhances patient care but also paves the way for future advancements in the field.